In neuroblastoma cell lines, STAT5B has been reported as a target of 5-aza-2′-deoxycytidine treatment to induce cell apoptosis and inhibit cell proliferation by changing the expression level of genes involved in the JAK/STAT pathway [136], indicating its important role. The gene discussed is STAT5B; the disease is neuroblastoma.